|
Letrozole Superior To Tamoxifen In Breast Cancer
The aromatase inhibitor letrozole (Femara) produces a significant survival benefit over tamoxifen when used as adjuvant therapy for postmenopausal women with endocrine-responsive breast cancer, according to updated results of a major trial released in a plenary session at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS)...
More... |
| All times are GMT -7. The time now is 06:10 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021